Original Research

What pricing and reimbursement policies to use for off-patent biologicals? – Results from the second EBE biological medicines policy survey

Author(s): , ,

Abstract: Objective: Biosimilar policies with a focus on uptake have received a lot of attention at national and regional level in the last few years. It is now 10 years… Read More »

Do pricing and usage-enhancing policies for biosimilar medicines differ from generic policies? Findings from a PPRI survey with competent authorities in 42 countries

Author(s): ,

Abstract: Study Objectives: The article aims to survey policies that European countries implemented for pricing and promoting the use of biosimilar medicines and to explore possible similarities and differences between policies… Read More »

Page 4 of 4 « Previous1 2 3 4
Go Back Print